摘要
目的:观察不同剂量来曲唑(LE)对耐克罗米酚的多囊卵巢综合征(PCOS)患者促排卵治疗的临床疗效。方法:回顾性分析73例耐克罗米酚的PCOS患者的临床资料。结果:本组均未出现卵巢过度刺激综合征(OHSS)及多胎妊娠。结论:芳香化酶抑制剂-来曲唑可以用于对耐克罗米酚的PCOS患者促排卵治疗,促排卵的效果与剂量有关,妊娠率与剂量无关,临床应用过程中未见明显不良反应。
Objective :To observe the clinical effect of various doses of letrozole for ovulation induction in clomiphene (CC)-resistant patients with ploycystic ovary syndrome (PCOS).Methods :The clinical data in 73 clomiphene-resistant patients with PCOS were analysed retrospectively.Results :The ovary overstimulation syndrome and multiple pregnancy were not found in this group.Conclusion:The various doses of letrozole can be used as a medicine for ovulation induction in clomiphene-resistant patients with PCOS.The effect of ovulation induction is associated with dose of letrozole, but the pregnancy rate is not associated with dose of letrozole, without obvious adverse reaction.
出处
《现代医药卫生》
2008年第21期3197-3198,共2页
Journal of Modern Medicine & Health
关键词
多囊卵巢综合征
来曲唑
克罗米酚
促排卵
卵泡发育
PCOS
Letrozole
Clomiphene critate
Ovulation induction
Follicular development